Continuous Glucose Monitor (CGM)
Continuous Glucose Monitor (CGM) is a medical device with 22 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.7%
11 of 12 finished
8.3%
1 ended early
4
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
Clinical Trials (22)
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes
Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients
Continuous Glucose Monitoring in Hospitalized Patients With Diabetes Mellitus
A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diabetes Mellitus
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions
Mechanisms for Restoration of Hypoglycemia Awareness
Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population
Continuous Glucose Monitoring During and After Surgery
CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2))
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma
Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)
CGM Use in Islet Transplant Recipients
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 22